During the past two decades, significant advances have been made in the area of controlled release as evidenced by an increasing number of patents, publications, as well as commercial controlled-release products for the delivery of a variety of bioactive agents. Here, an attempt is made to formulate the matrix type transdermal films of quetiapine fumerate, an anti-psychotic drug using various polymers to sustain its action and evaluate the prepared films using various parameters.